AJA Pharma, Novartis to launch SAR 50 mln production line

30/05/2018 Argaam

 

AJA Pharma Co. Ltd, subsidiary of Saudi Chemical Company, signed an agreement with global pharmaceutical firm Novartis to manufacture pharmaceutical products for the treatment of diabetes and blood pressure in the Kingdom, Saudi Press Agency (SPA) reported.

 

Under the deal, an investment of SAR 50 million will go into a production line at AJA’s Hail plant.

 

The expected value of the nationally manufactured drugs amounts to over SAR 1 billion within the next five years.

 

The project will provide more than 30 new job opportunities for Saudis in the pharmaceutical field during the first year.

 

AJA has built a pharmaceutical plant in Hail over a 120,000 square-meter land, where it launched trial operations recently.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.